Supernus Announces Webcast of Investor Day on June 17, 2015
During the meeting, members of Supernus' senior management team will provide a detailed discussion of the Company's clinical programs, including efficacy and safety results for completed trials of its two late stage clinical programs, plans for prospective clinical trials, and an assessment of their market opportunity. In addition, several key thought leaders will share their perspectives on the current treatment paradigms, unmet medical needs, and the Company's clinical development programs.
Presentation Date:
Time:
Place:
Registration and details are available via the Company's Investor Day webpage located here.
A live webcast of the presentation can be accessed by visiting 'Events & Presentations' in the Investors Section on the Company's website at www.supernus.com. An archived replay of the webcast will be available on the Company's website.
About
CONTACT:Source:Jack A. Khattar , President and CEOGregory S. Patrick , Vice President and CFOSupernus Pharmaceuticals, Inc. Tel: (301) 838-2591 Or Investor Contact:Peter Vozzo Westwicke Partners Office: (443) 213-0505 Mobile: (443) 377-4767 Email: peter.vozzo@westwicke.com
News Provided by Acquire Media